International Journal of Radiation Oncology * Biology * Physics
Volume 64, Issue 4 , Pages 1023-1030, 15 March 2006

Whole-brain radiotherapy with or without efaproxiral for the treatment of brain metastases: Determinants of response and its prognostic value for subsequent survival

Presented in part at the Ninth Annual Scientific Meeting of the Society for Neuro-Oncology, Toronto, Canada, November 2004, and the 46th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), Atlanta, GA, October 3–7, 2004.

  • Baldassarre Stea, M.D., Ph.D.

      Affiliations

    • University of Arizona Health Sciences Center, Tucson, AZ
    • Corresponding Author InformationReprint requests to: Baldassarre Stea, M.D., Ph.D., The University of Arizona Health Sciences Center, Department of Radiation Oncology, 1501 North Campbell Avenue, Tucson, AZ 85724. Tel: (520) 694-7236; Fax: (520) 626-3141
    • ,
  • John H. Suh, M.D.

      Affiliations

    • Cleveland Clinic, Cleveland, OH
    • ,
  • Adam P. Boyd, M.S.

      Affiliations

    • Allos Therapeutics, Inc., Westminster, CO
    • ,
  • Pablo J. Cagnoni, M.D.

      Affiliations

    • Allos Therapeutics, Inc., Westminster, CO
    • ,
  • Edward Shaw, M.D.

      Affiliations

    • Wake Forest University School of Medicine, Winston-Salem, NC
    • ,
  • REACH Study Group

Received 22 August 2005; received in revised form 11 October 2005; accepted 11 October 2005. published online 31 January 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Sponsored by Allos Therapeutics, Inc., Westminster, Colorado.

PII: S0360-3016(05)02739-2

doi:10.1016/j.ijrobp.2005.10.004

International Journal of Radiation Oncology * Biology * Physics
Volume 64, Issue 4 , Pages 1023-1030, 15 March 2006

Article Tools

* Image Usage & Resolution